Bispecific antibodies in cancer therapy, from the laboratory to the clinic

R Koelemij; PJK Kuppen; CJH van de Velde; GJ Fleuren; M Hagenaars; Lex Eggermont

doi:10.1097/00002371-199911000-00006

Bispecific antibodies in cancer therapy, from the laboratory to the clinic

R Koelemij
, PJK Kuppen
, CJH van de Velde
, GJ Fleuren
, M Hagenaars
, Lex Eggermont

Surgery

Research output: Contribution to journal › Article › Academic › peer-review

22 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	514-524
Number of pages	11
Journal	Journal of Immunotherapy
Volume	22
Issue number	6
DOIs	https://doi.org/10.1097/00002371-199911000-00006
Publication status	Published - 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-47-11

Access to Document

10.1097/00002371-199911000-00006

http://hdl.handle.net/1765/64795

Cite this

@article{f789cf13b0914c6bbab81ee781dc638a,

title = "Bispecific antibodies in cancer therapy, from the laboratory to the clinic",

author = "R Koelemij and PJK Kuppen and \{van de Velde\}, CJH and GJ Fleuren and M Hagenaars and Lex Eggermont",

year = "1999",

doi = "10.1097/00002371-199911000-00006",

language = "Undefined/Unknown",

volume = "22",

pages = "514--524",

journal = "Journal of Immunotherapy",

issn = "1053-8550",

publisher = "Lippincott Williams \& Wilkins",

number = "6",

}

TY - JOUR

T1 - Bispecific antibodies in cancer therapy, from the laboratory to the clinic

AU - Koelemij, R

AU - Kuppen, PJK

AU - van de Velde, CJH

AU - Fleuren, GJ

AU - Hagenaars, M

AU - Eggermont, Lex

PY - 1999

Y1 - 1999

U2 - 10.1097/00002371-199911000-00006

DO - 10.1097/00002371-199911000-00006

M3 - Article

SN - 1053-8550

VL - 22

SP - 514

EP - 524

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

IS - 6

ER -